EU and CELAC strengthen their drug policy cooperation at a high-level meeting in Brussels
Representatives of 42 National Drug Agencies from Latin America, the Caribbean and the European Union took part in a high-level...
Anti-drug prosecutors approve recommendations to improve investigations into the environment and drug trafficking
The Ibero-American Network of Anti-Drug Prosecutors (RFAI), part of the Ibero-American Association of Public Prosecutors (AIAMP), approved last week at...
Diagnosis
This Diagnosis, promoted by the Ibero-American Association of Public Prosecutors (AIAMP) and the European Union's COPOLAD III Program, is the...
Drug Trafficking and Its Impact on the Environment
This document, created by the Ibero-American Association of Public Prosecutors (AIAMP) and the European Union's COPOLAD Program, outlines certain guidelines,...
High-Level Seminar of the National Drug Agencies of the EU and CELAC
Representatives of 42 National Drug Agencies from Latin America, the Caribbean and the European Union took part in a high-level biregional...
Colombia adopts new comprehensive policy to address problematic drug use
The Government of Colombia, through the Ministry of Health and Social Protection, officially adopted the Comprehensive Policy for the Prevention,...
Person-centred, evidence-based treatment guide for fentanyl and methamphetamine use disorders in Mexico
This Guide is the result of technical cooperation between the National Commission for Mental Health and Addictions (CONASAMA) and the...
Mexico strengthens the training of health personnel to address fentanyl and methamphetamine use
The National Commission for Mental Health and Addictions of Mexico (CONASAMA), in collaboration with the COPOLAD III Programme and Episteme...
Evaluation of Costa Rica’s Drug Policy (2005-2025)
This study is part of the COPOLAD III Programme, within Working Group 1.4 on Drug Policy Evaluation, in close collaboration...
Costa Rica assesses the last 20 years of its drug policies
On Thursday, 13 November, the Costa Rican Drug Institute (ICD) presented the main findings and recommendations on the evaluation of...
COPOLAD is a consortium formed by:
Collaborating partners:
